GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 58 filers reported holding GEMINI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $45,000 | -15.1% | 27,351 | -11.7% | 0.00% | – |
| Q2 2022 | $53,000 | +26.2% | 30,985 | +0.1% | 0.00% | – |
| Q1 2022 | $42,000 | -40.8% | 30,952 | +26.6% | 0.00% | – |
| Q4 2021 | $71,000 | +22.4% | 24,450 | +67.5% | 0.00% | – |
| Q3 2021 | $58,000 | -70.1% | 14,598 | -51.3% | 0.00% | – |
| Q2 2021 | $194,000 | -41.6% | 29,976 | +22.4% | 0.00% | – |
| Q1 2021 | $332,000 | – | 24,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Running Point Capital Advisors, LLC | 10,000 | $13,500 | 0.01% |
| Ulland Investment Advisors, LLC | 0 | $0 | 0.00% |